Research Reports

Needle-free Blood Drawing Devices Market is Predicted to See Lucrative Gains Over 2021-2027 Covid-19 Analysis

Published by Coherent Market Insights

Posted on September 14, 2021

3 min read

· Last updated: February 10, 2026

Add as preferred source on Google
Lawmaker Kim Leadbeater discusses UK's assisted dying law changes - Global Banking & Finance Review
Image of Kim Leadbeater addressing the media about proposed changes to the UK's assisted dying law, emphasizing the removal of High Court judge sign-off to enhance the legislative process.
Global Banking & Finance Awards 2026 — Call for Entries

A needle free blood drawing device is an innovative concept that has become extremely popular over the past few years. These draws have become extremely popular in hospitals and are used by many patients that don’t want to get blood drawn or have medical issues that would make it necessary to have their blood drawn. […]

Growth Forecast for Needle-Free Blood Drawing Devices from 2021 to 2027

A needle free blood drawing device is an innovative concept that has become extremely popular over the past few years. These draws have become extremely popular in hospitals and are used by many patients that don’t want to get blood drawn or have medical issues that would make it necessary to have their blood drawn. If anyone is thinking about getting blood drawn but doesn’t want to have their blood drawn with a needle, then some companies can do this. These companies will draw blood with needle free blood drawing.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/120

Many organizations draw blood by needle free blood drawing device and although most of them use the same type of equipment, there are variations as far as the process goes. Many people are very sensitive to the fact that there is some cleaning, and disinfecting that needs to take place before a blood draw.

The increasing cases of the virus and bacteria-related illnesses in the world are the main factor that is enhancing the growth of the global needle free blood drawing device market. For instance, according to the Centers for Disease Control and Prevention, in the world, there are more than 1.2 million bacterial meningitis cases that occur each year. The case fatality and incidence rates for bacterial meningitis depend on age group, pathogen, country, and region. Moreover, the low cost and reduced risk factors of a needleless blood drawing are also aiding the growth of the global needle free blood drawing device market.

Patients will need to research the different companies that offer needle-free blood and make sure that they find one that offers them a high-quality service at a reasonable price. Once they find a company that they feel comfortable with, the company will ask for contact information so that they can set up a time to come in and have the blood drawn. Needle free blood will be provided on the same day that patients make the appointment, so patients don’t have to worry about any complications later. However, the lesser availability of this method is the main restraining factor that is negatively affecting the growth of the global needle free blood drawing device market.

With the increase in pathogens-related illnesses in the region, North America is experiencing high demand in the global needle free blood drawing device market. For instance, according to Medscape Reference over 10,000 cases of viral meningitis are reported every year, however, the actual increase can be as high as 75000. The lack of reporting the cases is owing to the uneventful clinical results of most cases along with some of the viruses that grow during culture. Owing to these factors, there have been various industrial developments in the global needle free blood drawing device market. For instance, in May 2019, Velano Vascular, which is a U.S.-based organization received around US$ 10 million in funding from its investor Intermountain Healthcare, for its Food and Drug Administration approval of its needle-free blood drawing device PIVO.

Top Key Players Include In Needle-free Blood Drawing Devices Market: Velano Vascular, VertMarkets, Inc., Gizmag Pty Ltd, Romsons, Alpha Bio Labs, and Poly Medicure Ltd.

Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/120

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

The post Needle-free Blood Drawing Devices Market is Predicted to See Lucrative Gains Over 2021-2027 Covid-19 Analysis appeared first on Gatorledger.

Frequently Asked Questions

What is a needle-free blood drawing device?
A needle-free blood drawing device is an innovative concept that allows for blood collection without the use of needles, making it popular among patients and healthcare providers.
What factors are driving the growth of the needle-free blood drawing device market?
The increasing cases of virus and bacteria-related illnesses globally are enhancing the growth of the needle-free blood drawing device market.
Which regions are experiencing high demand for needle-free blood drawing devices?
North America is experiencing high demand for needle-free blood drawing devices due to the rise in pathogen-related illnesses.
Who are the key players in the needle-free blood drawing device market?
Top key players include Velano Vascular, VertMarkets, Inc., Gizmag Pty Ltd, Romsons, Alpha Bio Labs, and Poly Medicure Ltd.
What should patients consider when choosing a needle-free blood drawing service?
Patients should research different companies offering needle-free blood drawing services to ensure they find one that provides high-quality service at a reasonable price.

Tags

Related Articles

More from Research Reports

Explore more articles in the Research Reports category